Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 21 von 82

Details

Autor(en) / Beteiligte
Titel
Randomized, controlled clinical study to evaluate efficacy of novel indigenously designed controlled release flurbiprofen gel system for management of periodontal diseases
Ist Teil von
  • Contemporary clinical dentistry, 2013-01, Vol.4 (1), p.32-36
Ort / Verlag
India: Medknow Publications Pvt Ltd
Erscheinungsjahr
2013
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
  • Background: This randomized, controlled clinical study was planned to evaluate the use of anti-inflammatory drug flurbiprofen in the form of locally delivered controlled release gel in the treatment of periodontal disease. Materials and Methods: The flurbiprofen gel was indigenously prepared in the concentration of 0.3%. The 30 patients with localized periodontal pockets measuring ≥5 mm were randomly divided into three groups. The groups received flurbiprofen gel, flurbiprofen gel after prophylaxis, and placebo gel after oral prophylaxis, respectively. The clinical parameters for plaque and gingival inflammation were evaluated at baseline, 7 th day, and 14 th day. Results: The results of the study suggested the statistically significant ( P < 0.05) improvement in the gingival status of the patients with the use of flurbiprofen gel as an adjunct to scaling and root planing as compared to oral prophylaxis or gel alone. Conclusion: The data demonstrated that the additional use of local drug delivery of flurbiprofen through gel media enhances the positive effects of scaling and root planing and helps in faster resolution of the inflammation.
Sprache
Englisch
Identifikatoren
ISSN: 0976-237X
eISSN: 0976-2361
DOI: 10.4103/0976-237X.111591
Titel-ID: cdi_doaj_primary_oai_doaj_org_article_01cba3bf96d84273bc5f0633815427dd

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX